IR Biosciences Holdings Inc. Stock Other OTC
Equities
IRBS
US46264M3034
Biotechnology & Medical Research
Financials (USD)
Sales 2009 | - | Sales 2010 | - | Capitalization | 1.2M |
---|---|---|---|---|---|
Net income 2009 | -6M | Net income 2010 | -5M | EV / Sales 2009 | - |
Net Debt 2009 | 5.81M | Net Debt 2010 | 3.67M | EV / Sales 2010 | - |
P/E ratio 2009 |
-0.37
x | P/E ratio 2010 |
-0.2
x | Employees | - |
Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03-06-30 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 04-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 03-06-30 |
1st Jan change | Capi. | |
---|---|---|
+3.13% | 43.43B | |
+48.71% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |